Xintela AB (publ) announced it is expanding and strengthening its management team with Peter Ekolind as COO (Chief Operating Officer) and Thomas Areschoug as CBO (Chief Business Officer). Sven Kili, who has had a combined role as COO and CMO (Chief Medical Officer), will focus on his role as CMO. Peter Ekolind has extensive experience of marketing, sales and leadership in several global pharmaceutical companies in various senior positions such as marketing- business area- and country manager. He has also been CEO of Getinge Sverige AB and the medtech company Avidicare AB. Thomas Areschoug, who has extensive experience in biomedical research and development as well as business development in Life Science, most recently came from a leading role at Business Sweden. Sven Kili, who is an orthopedic surgeon and expert in cell and gene therapy, has previously had a combined role as both COO and CMO in Xintela. Sven will now focus on his role as CMO to support the company in its clinical development work.